ES2013321A6 - Monoclonal antibodies to Pseudomonas aeruginosaflagella - Google Patents

Monoclonal antibodies to Pseudomonas aeruginosaflagella

Info

Publication number
ES2013321A6
ES2013321A6 ES878701936A ES8701936A ES2013321A6 ES 2013321 A6 ES2013321 A6 ES 2013321A6 ES 878701936 A ES878701936 A ES 878701936A ES 8701936 A ES8701936 A ES 8701936A ES 2013321 A6 ES2013321 A6 ES 2013321A6
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
antibodies
aeruginosaflagella
pseudomonas
bind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES878701936A
Other languages
Spanish (es)
Inventor
Mark E Lostrom
Anthony W Siadak
Mae Joanne Rosok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Systems Corp
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of ES2013321A6 publication Critical patent/ES2013321A6/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Cell lines have been produced that secrete monoclonal antibodies which bind to the flagellar proteins of selected Pseudomonas aeruginosa strains. Some of these antibodies have been found to be protective against lethal challenges of P. aeruginosa. Pharmaceutical compositions containing these antibodies, can be used singly or in combination with other monoclonal antibodies, blood plasma fractions and antimicrobial agents, to form prophylactic and therapeutic compositions.
ES878701936A 1986-07-03 1987-07-02 Monoclonal antibodies to Pseudomonas aeruginosaflagella Expired - Fee Related ES2013321A6 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US4814387A 1987-05-15 1987-05-15

Publications (1)

Publication Number Publication Date
ES2013321A6 true ES2013321A6 (en) 1990-05-01

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES878701936A Expired - Fee Related ES2013321A6 (en) 1986-07-03 1987-07-02 Monoclonal antibodies to Pseudomonas aeruginosaflagella

Country Status (19)

Country Link
JP (1) JP2639422B2 (en)
KR (1) KR910002373B1 (en)
AT (1) AT399885B (en)
AU (1) AU615162B2 (en)
BE (1) BE1000743A3 (en)
CH (1) CH677796A5 (en)
DE (1) DE3722098C2 (en)
DK (1) DK172840B1 (en)
ES (1) ES2013321A6 (en)
FR (1) FR2601458B1 (en)
GB (1) GB2192185B (en)
IE (1) IE60888B1 (en)
IL (1) IL83047A (en)
IT (1) IT1221940B (en)
LU (1) LU86938A1 (en)
NL (1) NL194961C (en)
OA (1) OA08629A (en)
PT (1) PT85247B (en)
SE (1) SE506421C2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
JPH02299594A (en) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd Human monoclonal antibody and production thereof
WO1990013033A1 (en) * 1989-04-14 1990-11-01 Biocontrol Systems, Incorporated Process and device for detecting a particular motile organism
DE69131861T2 (en) * 1990-01-18 2000-05-18 Cura Nominees Pty Ltd GLYCOAL CALALID
EP2393515A1 (en) * 2009-02-04 2011-12-14 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
EP2542577A1 (en) * 2010-03-01 2013-01-09 Lostam Biopharmaceuticals Ltd Improved therapeutic antibodies against flagellated pseudomonas aeruginosa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (en) * 1984-09-26 1997-12-17 住友製薬株式会社 Human monoclonal antibody and method for producing the same
AU5991786A (en) * 1985-06-06 1987-01-07 Genetic Systems Corporation Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella

Also Published As

Publication number Publication date
ATA168387A (en) 1994-12-15
IL83047A0 (en) 1987-12-31
KR910002373B1 (en) 1991-04-20
KR880001815A (en) 1988-04-27
AU7495887A (en) 1988-01-07
FR2601458A1 (en) 1988-01-15
JP2639422B2 (en) 1997-08-13
PT85247B (en) 1990-06-29
IE871769L (en) 1988-01-03
LU86938A1 (en) 1988-02-02
NL194961B (en) 2003-05-01
NL194961C (en) 2003-09-02
GB2192185A (en) 1988-01-06
IE60888B1 (en) 1994-08-24
DE3722098A1 (en) 1988-03-03
AT399885B (en) 1995-08-25
NL8701554A (en) 1988-02-01
BE1000743A3 (en) 1989-03-28
PT85247A (en) 1987-08-01
AU615162B2 (en) 1991-09-26
CH677796A5 (en) 1991-06-28
IT1221940B (en) 1990-08-31
GB2192185B (en) 1991-01-16
SE8702734D0 (en) 1987-07-02
DE3722098C2 (en) 1998-06-04
GB8715347D0 (en) 1987-08-05
IT8721163A0 (en) 1987-07-02
IL83047A (en) 1992-12-01
SE506421C2 (en) 1997-12-15
FR2601458B1 (en) 1992-08-21
SE8702734L (en) 1988-01-04
JPS63102697A (en) 1988-05-07
DK336687D0 (en) 1987-06-30
DK172840B1 (en) 1999-08-09
OA08629A (en) 1988-11-30
DK336687A (en) 1988-01-04

Similar Documents

Publication Publication Date Title
NO964966D0 (en) Lactobacillus strains of human origin, mixtures and their use
SE8605295D0 (en) MONOCLONAL ANTIBODIES CROSS-REACTIVE AND CROSSPROTECTIVE AGAINST P. AERUGINOSA SEROTYPES
LTC1131065I2 (en) Dialkyl fumarates for the treatment of autoimmune diseases
IT8719081A0 (en) COMPLEXES OF BIOFLAVONOIDS WITH PHOSPHOLIPIDS, THEIR PREPARATION, USE AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS.
NZ306653A (en) Isolated dna il-17 receptors
EA199800946A1 (en) CONCENTRATED ANTIBODY PREPARATION
ES2062355T3 (en) PHARMACEUTICAL COMPOSITION INCLUDING LORATADINE, IBUPROPHEN AND PSEUDOEFEDRINE.
ES2009140A6 (en) Cross-protective human monoclonal antibody compositions
GR3007385T3 (en)
ES2013321A6 (en) Monoclonal antibodies to Pseudomonas aeruginosaflagella
DE69927584D1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF STOMACH DISEASES
ATE188873T1 (en) TRIS PLATINUM COMPLEXES
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DK0391185T3 (en) 1,8-naphthyridines
ES8707296A1 (en) PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO -i(PSEUDOMONAS AERUGINOSA) EXOTOXIN A.
MD970269A (en) Clavulanates
ATE395064T1 (en) COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYLPHOSPHONY ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYLPHOSPHONY ACID DERIVATIVES WITH SPECIAL PHARMACEUTICAL ACTIVE INGREDIENTS
ATE338819T1 (en) ANTIGENIC PROTEIN FROM MALASSEZIA
AU564439B2 (en) Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
IT8722631A0 (en) HIGHLY BIOAVAILABLE AND TOLERABLE IRON PROTEIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
CA1263380C (en) C-23-substituted mycaminosyltylonolide compounds and pharmaceutical compositions thereof
AU1507300A (en) Pharmaceutical compositions containing proteins
MX9100974A (en) HYBRID FIBRINOLYTIC ENZYME AND PROCEDURE FOR ITS PREPARATION.
UA29528C2 (en) Preparation for treating torch infections

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070703